Detalhe da pesquisa
1.
"TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure".
Channels (Austin)
; 13(1): 1-16, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30424709
2.
A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates.
Front Immunol
; 9: 2464, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467501
3.
Two-pore channel 1 interacts with citron kinase, regulating completion of cytokinesis.
Channels (Austin)
; 9(1): 21-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25665131
4.
The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.
Oncoimmunology
; 3(1): e28288, 2014 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24800179
5.
The calcium release-activated calcium channel Orai1 represents a crucial component in hypertrophic compensation and the development of dilated cardiomyopathy.
Channels (Austin)
; 8(1): 35-48, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24135962
6.
Successful TRPV1 antagonist treatment for cardiac hypertrophy and heart failure in mice.
Channels (Austin)
; 7(1): 17-22, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23221478
7.
Relaxin and preterm birth.
Ital J Anat Embryol
; 118(1 Suppl): 21-2, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24640563
8.
Identification of relaxin-responsive cells in the human choriodecidua at term.
Ann N Y Acad Sci
; 1160: 136-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19416174